Status:
COMPLETED
Anticoagulant Clinics and Vitamin K Antagonists
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Blood Coagulation Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background: Whether the management of vitamin K antagonists (VKA) therapy by general practitioners with the collaboration of anticoagulation clinics (ACC) provides better clinical outcomes than that a...
Detailed Description
Study design The COMPARE (Comparison of Oral anticoagulation Monitoring Practice: A Randomized Evaluation) study is an open, centrally randomized, multicenter, prospective, controlled study comparing...
Eligibility Criteria
Inclusion
- inpatients and outpatients who are starting a course of VKA therapy scheduled to last for at least three months
Exclusion
- life expectancy of less than three months
- contraindication to anticoagulant therapy because of bleeding risk
- refusal of his/her general practitioner to participate in the study
- no general practitioner likelihood of poor follow-up or poor compliance (e.g., patients unable to care for themselves, lacking adequate home support or unwilling to comply with the treatment care plan)
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
1006 Patients enrolled
Trial Details
Trial ID
NCT00966290
Start Date
February 1 2003
End Date
December 1 2006
Last Update
August 26 2009
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Brest, France, 29609
2
Louis Pasteur Hospital
Dole, France, 39100
3
University Hospital
Lille, France, 59037
4
Dupuytren University Hospital
Limoges, France, 87042